Skip to main content
Donate

2015 FAST Summit & Gala

  GalaSponsor2


Science Summit

Becky Burdine, Ph.D. ~Introduction/Therapeutics in Angelman Syndrome Ovid Therapeutics ~The use of Gaboxadol (OV101) in the treatment of Angelman Syndrome. Down stream therapeutics working at the neuronal synapse.  Discussion of future clinical trials. Agilis Biotherapeutics ~ The use of gene therapy for the production of UBE3A in the treatment of Angelman Syndrome.  Discussion of future clinical trials. Disruptive Nutrition ~ The use of Ketone Supplements for the nutritional management of Angelman Syndrome.  Discussion of pre-clinical trial outcomes and future human clinical trials. Vivint ~ The use of a smart technology home security system to protect your loved ones. FAST FIRE Team The most aggressive, novel, innovative research initiative whose goal is to identify treatments for Angelman Syndrome. FIRE Team Q&A 

Educational Summit 

Linda Burkhart & Gayle Porter ~ Information to clarify desirable long-term outcomes and evidence informed practices towards the development of accessible, autonomous communication for children who use AAC. Q&A/Panel Discussion David Koppenhaver & Susan Norwell ~ Key principles and strategies including structured shared reading, predictable chart writing, independent emergent reading and writing, and early skills instruction.  The use of Core Vocabulary and Soft-Tech Reading Page Sets and how they support communication during shared reading.  Decision tree for determining when emergent literacy or conventional literacy instruction is most appropriate. Q&A/Panel Discussion  

Disclaimer

This website contains information for a broad audience and may include information on current and upcoming programs that are not yet approved or accessible The information provided is for general informational purposes only and is not intended as medical advice, diagnosis, or treatment. While FAST strives to provide accurate and up-to-date information, the content on this site may not always reflect the most current research or clinical guidelines. The inclusion of clinical trial information, treatments or specific healthcare providers does not imply endorsement, recommendation or guarantee of safety, efficacy, or availability. Reliance on any information provided by this website is solely at your own risk. FAST disclaims any liability for any errors or omissions in the information provided or for any decisions made based on this information. For personalized medical advice or specific health concerns including participation in any clinical trial, please consult a qualified healthcare professional.